Related Experiment Videos
Sentinel lymph node biopsy reveals a positive popliteal node in clear cell sarcoma
Yoshihiro Nishida1, Yoshihisa Yamada, Satoshi Tsukushi
1Department of Orthopaedic Surgery, Nagoya University School and School of Medicine, 65-Tsurumai, Showa, 466-8550, Japan. ynishida@med.nagoya-u.ac.jp
Anticancer Research
|December 13, 2005
Summary
Sentinel lymph node biopsy can detect metastases in clear cell sarcoma, a rare soft tissue tumor. Early detection via popliteal lymph node biopsy may guide adjuvant radiotherapy for improved local control.
Area of Science:
- Oncology
- Surgical Pathology
- Soft Tissue Tumors
Background:
- Clear cell sarcoma of the tendons and aponeuroses is a rare and aggressive malignancy.
- Metastasis to regional lymph nodes is common in clear cell sarcoma.
- Sentinel lymph node biopsy is a standard procedure for melanoma staging.
Observation:
- Sentinel lymph node biopsy was employed to assess lymph node involvement in clear cell sarcoma.
- Isosulfan blue staining was used to identify sentinel lymph nodes in the popliteal and groin regions.
- One popliteal lymph node showed malignancy, while all groin lymph nodes were negative.
Findings:
- Sentinel lymph node biopsy successfully identified a metastatic lymph node in clear cell sarcoma.
- The technique allowed for precise staging of regional lymph node status.
- Adjuvant radiotherapy (50 Gy) to the positive popliteal node may have contributed to local control for one year.
Implications:
- Sentinel lymph node biopsy is a feasible and valuable tool for staging clear cell sarcoma.
- This approach can inform the need for adjuvant therapies like radiotherapy.
- Further research is warranted to optimize the management of clear cell sarcoma based on lymph node status.